Key points are not available for this paper at this time.
In recent years, germline gain-of-function (GOF) mutations in signal transducer and activator of transcription 3 (
Saito et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: